Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
eNq1mN9v2jAQx9/5K6K8kxD6AzoFqo21G1KrMlq0aS+VSY5i5trp2aZ0f/0cQjc6OWpr8GNs53tn393HJ6enq3sWLAElFbwXJlErDIBnIqf8rhdObs6b3fC030gXZEm2lnWiVpS0wyBjRMpeWM5GUyBcRj8uLz6D+R8w7DeCVEwXkKkX67SiLPpK5PySFOWaIF0Kmgf3oOYi74WFVuvRIJUKjRf9R4G/ZEEySOPNyPbs4vZwezyNS7E3qGoJeEH4nVUUuJNmphGBqwFRcCfwqcbfAydtKscghcYMRkTNRyiWNIfcamJGmAQnI7PH/BpwyUCVRqzi8SK7l07iZEFWY3gY2p3+aGYHaqWarWbSOU4O2p1WctI97DqZwq2jskfBbCLObpNOu33SOoiBx4xwpaVjaEYCFWGegkLl4GVeebKD8PBq8HMqC0aeooUsXI+KIDHTgKb6/W2k3MENGh4xc2b/6XPNWPxOrycbWnjyuITRQGiuaqBxPnY9iIHgClb1EXXjnFptcpGC3J/sb8HtjB/pKaOZK9EMczRINRkP64G2RxZ8IhIm6A8G3ynPxaPcP2S2g+rJ+2LNSatogXly2z7pHidHR8419NNkUM39cqZRFBAb/FC5C1WGfCZ25YlJSrvUc0ruKxvXTY7ICIOaNqfpSBaThs9dmbdE91dE1YRV9MvZjWt2fNOAT9frT6s0zXt/4+qGXR8sN7lY6/j7M7sqcC8NsEY7OOZKFfJDHM+JbEpTKhDNcN9M37pF/XXeXq7qqnWpuOjJ9Wl14b09OK4F9tpFvmtzuvl/0wRbbSjUsEMcKhZ7I+bwbP8Q/teZenN79AIa/sysu0iiqOC+2hs9tSruhn0TV36OBg5XsxmteQWpzcs0rl5g+o00Ll9f+o0/ZTHgFQ==
cTRLyAh20VKcgjZ4
Listen
